Prelude Capital Management’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,241
| Closed | -$383K | – | 1498 |
|
|
2025
Q3 | $383K | Buy |
+1,241
| New | +$389K | 0.03% | 607 |
|
|
2024
Q4 | – | Sell |
-3,140
| Closed | -$731K | – | 1479 |
|
|
2024
Q3 | $731K | Buy |
+3,140
| New | +$645K | 0.04% | 476 |
|
|
2024
Q1 | – | Sell |
-8,694
| Closed | -$1.89M | – | 1490 |
|
|
2023
Q4 | $1.89M | Buy |
8,694
+5,279
| +155% | +$905K | 0.13% | 182 |
|
|
2023
Q3 | $545K | Buy |
+3,415
| New | +$765K | 0.04% | 450 |
|
|
2023
Q2 | – | Sell |
-1,741
| Closed | -$555K | – | 1306 |
|
|
2023
Q1 | $555K | Buy |
+1,741
| New | +$516K | 0.03% | 425 |
|
|
2022
Q4 | – | Sell |
-1,661
| Closed | -$381K | – | 1549 |
|
|
2022
Q3 | $381K | Sell |
1,661
-986
| -37% | -$247K | 0.01% | 765 |
|
|
2022
Q2 | $577K | Buy |
2,647
+274
| +12% | +$62.3K | 0.02% | 743 |
|
|
2022
Q1 | $632K | Buy |
+2,373
| New | +$582K | 0.02% | 747 |
|
|
2021
Q4 | – | Sell |
-1,974
| Closed | -$561K | – | 2199 |
|
|
2021
Q3 | $561K | Sell |
1,974
-7,290
| -79% | -$2.08M | 0.01% | 830 |
|
|
2021
Q2 | $2.54M | Buy |
9,264
+3,484
| +60% | +$947K | 0.08% | 222 |
|
|
2021
Q1 | $1.51M | Buy |
5,780
+2,907
| +101% | +$779K | 0.04% | 436 |
|
|
2020
Q4 | $734K | Buy |
2,873
+601
| +26% | +$149K | 0.02% | 581 |
|
|
2020
Q3 | $538K | Buy |
2,272
+74
| +3% | +$15.6K | 0.03% | 426 |
|
|
2020
Q2 | $427K | Buy |
+2,198
| New | +$420K | 0.02% | 509 |
|
|
2020
Q1 | – | Sell |
-398
| Closed | -$68K | – | 1906 |
|
|
2019
Q4 | $68K | Buy |
+398
| New | +$66.3K | ﹤0.01% | 1238 |
|
|
2019
Q2 | – | Sell |
-13,779
| Closed | -$1.31M | – | 2051 |
|
|
2019
Q1 | $1.31M | Buy |
13,779
+1,313
| +11% | +$113K | 0.07% | 273 |
|
|
2018
Q4 | $989K | Buy |
12,466
+2,028
| +19% | +$172K | 0.07% | 320 |
|
|
2018
Q3 | $1.11M | Sell |
10,438
-100
| -0.9% | -$9.36K | 0.06% | 351 |
|
|
2018
Q2 | $903K | Hold |
10,538
| – | – | 0.06% | 357 |
|
|
2018
Q1 | $913K | Buy |
10,538
+578
| +6% | +$44.9K | 0.07% | 302 |
|
|
2017
Q4 | $687K | Buy |
9,960
+2,122
| +27% | +$139K | 0.06% | 336 |
|
|
2017
Q3 | $432K | Buy |
7,838
+1,218
| +18% | +$66.5K | 0.04% | 422 |
|
|
2017
Q2 | $340K | Sell |
6,620
-119
| -2% | -$5.17K | 0.03% | 424 |
|
|
2017
Q1 | $290K | Buy |
6,739
+2,815
| +72% | +$121K | 0.03% | 443 |
|
|
2016
Q4 | $148K | Buy |
3,924
+3,424
| +685% | +$128K | 0.02% | 687 |
|
|
2016
Q3 | $20K | Buy |
+500
| New | +$19.8K | ﹤0.01% | 1342 |
|
Other funds holding PODD
Prelude Capital Management's PODD Position: Q4 2025 in Review
Prelude Capital Management sold out of Insulet (PODD) in Q4 2025, closing a stake of 1,241 shares — an estimated $383K sold.
Prelude Capital Management first reported a position in PODD in Q3 2016 and held it in 26 quarters. The position peaked at $2.54M in Q2 2021. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.
- Prelude Capital Management reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
- Prelude Capital Management sold 1,241 Insulet shares in Q4 2025, an estimated $383K.
- Prelude Capital Management first reported a position in Insulet in Q3 2016 and held it in 26 quarters.
- Prelude Capital Management's Insulet position peaked at $2.54M in Q2 2021.
- 832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.
Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.